Modulating gene expression is one of the most powerful techniques employed by researchers investigating the complex genetic networks governing biological processes. In particular, gene modulation experiments are used extensively to identify therapeutics effective in combatting diseases ranging from cancer to developmental and neurodegenerative disorders.
Numerous technologies exist for the effective regulation of gene expression in cells and tissues. RNAi (RNA interference) is a natural biological mechanism wherein siRNA (short interfering RNA) duplexes induce potent, targeted inhibition of gene expression. SigmaAldrich® Advanced Genomics has been a leader in developing commercial RNAi products for researchers.
More recently, the development of CRISPR inhibition (CRISPRi) and CRISPR activation (CRISPRa) gives researchers a powerful new set of tools that allows for almost unlimited gene regulation options. Utilizing the unparalleled portfolio of CRISPR products from SigmaAldrich® Advanced Genomics, researchers are able to accurately and efficiently knock-down, knock-out, activate or overexpress virtually any gene.
Functional genomics screens are an integral part of discovery research, allowing you to unravel the mechanisms that belie biological systems, pathways, and diseases. Effective interrogation of these complex molecular interaction networks can be accomplished using shRNA libraries to deliver reliable, efficient, and long-term knockdown.
Diagram showing the mechanistic flow of shRNA and siRNA mediated gene silencing in cells.
Sigma-Aldrich® Advanced Genomics is the exclusive provider of the TRC1.5 and TRC2 collections from The RNAi Consortium (TRC). These lentivirus-based shRNA libraries deliver unparalleled coverage and are available in multiple formats that include whole-genome, individual RNAi clones/vectors, and gene family sets.
CRISPRi (CRISPR interference) and CRISPRa (CRISPR activation) deliver highly efficient silencing and activation of genes, respectively, without altering the underlying DNA sequence. When employed in large scale LOF (loss-of-function) and GOF (gain-of-function) screens, researchers are able to identify unique, yet functionally related, gene pathways that are often missed with other methods.
Schematic diagrams of CRISPRa with the Synergystic Activation Mediator complex (SAM) and CRISPRi using the KRAB domain.
Sigma-Aldrich® Advanced Genomics offers a complete suite of optimized CRISPRi and CRISPRa libraries for gene knockdown and overexpression experiments. Pooled CRISPRi and SAM CRISPRa lentiviral libraries are available off-the-shelf or customized to your specific needs.
Wondering if CRISPR is right for your project? Connect with a Sigma-Aldrich® Advanced Genomics Expert.
Research. Development. Production.
We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.